Hsiri Therapeutics is a developing five compounds in important infectious disease areas.
Business Model:
Revenue: $19M
Employees: 51-200
Address: 650 Park Ave
City: King of Prussia
State: PA
Zip: 19406
Country: US
Hsiri Therapeutics is a development stage pharmaceutical company engaged in the discovery and development of new antibiotics to treat diseases caused by drug resistant bacteria. Hsiri Therapeutics’ efforts are primarily directed at two discrete groups of pathogens – mycobacterial diseases and gram-negative infections. Hsiri Therapetics was formed based on the antibiotic research that originated in the laboratories of Professor Marvin Miller at the University of Notre Dame.
Contact Phone:
+14846747603
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2015 | Seed Round | 1 | - |
BioAdvance BioAdvance |
12/2015 | Venture Round | 1 | - |
BioAdvance BioAdvance |
12/2015 | Venture Round | 1 | - |
BioAdvance BioAdvance |
1/2015 | Seed Round | 1 | - |
BioAdvance BioAdvance |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|